Sign in
4

Changes in Ownership

Neurogene Inc. Filed Acc 0001209191-18-030711

Director sold 3,906 shares at $12.67 ($49,489)

  • Director acquired 3,906 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

LEVITT DANIEL J · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-05-14 Exercise or conversion : show line 1 in the form +3,906 $10.56 $41,247 3,906 D
2018-05-14 Sale : show line 2 in the form −3,906 $12.67 $49,489 0 D
Open-market sales · 3,906 sh · avg $12.67 · $49,489

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-05-14 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −3,906 0 D
Loading xslF345X03/doc4.xml…